tm logo

Monitor this mark

View On USPTO

EYLUXVI
Live/Registered
REGISTERED

on 04 Jun 2024

Last Applicant/ Owned by

ALTOS BIOLOGICS, INC.

Yuseong-gu Daejeon 34054

KR

Serial Number

79369862 filed on 11th Apr 2023

Registration Number

7404257 registered on 04th Jun 2024

in the Principal Register

Correspondent Address

James E. Bame

James E. Bame IPLA P.A.

Los Angeles, CA 90010

UNITED STATES

Filing Basis

1. filing basis filed as 66 a

Disclaimer

NO DATA

EYLUXVI

Pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions; Pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions sold in prefilled syringes

Classification Information

Class [005]
Pharmaceutical Products

Pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions; Pharmaceuticals preparations for the treatment of ophthalmic diseases and conditions sold in prefilled syringes

First Use Date in General

N/A

First Use Date in Commerce

N/A

Mark Details

Serial Number

No 79369862

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 2382-03TM

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

Yes

66A Current

Yes

Current Basis

No

No Basis

No

Legal History

Show more

Status DateAction Taken
07th Dec 2024FINAL DECISION TRANSACTION PROCESSED BY IB
19th Nov 2024FINAL DISPOSITION PROCESSED
19th Nov 2024FINAL DISPOSITION NOTICE SENT TO IB
04th Sep 2024FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
04th Jun 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED
04th Jun 2024REGISTERED-PRINCIPAL REGISTER
19th Mar 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
19th Mar 2024PUBLISHED FOR OPPOSITION
28th Feb 2024NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
28th Feb 2024OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED